Data regarding immunohistochemistry-based measurements of proteinsinvolved in these pathways (eg, androgen receptor [AR] and aldehyde dehydrogenase 1[ALDH1], respectively) among diverse patient populations will therefore be valuablein the effort to use precision medicine techniques in addressing breast cancerdisparities. The gene discussed is AR; the disease is medical procedure.